2m 2m 2m 2m 2m 2m 2m
NRX PHARMA (NRXP)
NASDAQ
$3.81+$0.05 (+1.20%)
Price as of Jun 23, 2026 7:30 PM EDT- $166.9MMarket Cap
- 16.77%1-Year Change
- BiotechnologyIndustry
NRX PHARMA (NRXP)
$3.81+$0.05 (+1.20%)
NRXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.76 | ||
Change | -$0.14 (-3.59%) | ||
Open | $3.80 | ||
High | $3.93 | ||
Low | $3.72 | ||
Previous Close | $3.90 | ||
Volume | 800,233 | ||
30-Day Average Volume | 1,600,607 | ||
1-Week Change | -5.29% | ||
1-Month Change | 16.77% | ||
1-Year Change | 16.77% | ||
3-Year Change | -25.10% | ||
5-Year Change | -97.18% | ||
Fundamentals | |||
Shares Outstanding | 42.8M | ||
Total Assets | $11.9M | ||
Market Cap | $166.9M | ||
Enterprise Value | $160.2M | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$1.4M | ||
EBITDA | -$1.4M | ||
Net Working Capital | -$17.8M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | -117 | ||
Enterprise Value/Revenue | 150 | ||
P/B | -12 | ||
P/E | -98 | ||
PEG | -1 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/02/2024 | ||
Earnings & Revenue